Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Prevalence and outcomes of olfactory and gustatory dysfunctions in hospitalized SARS-CoV-2-infected patients

View through CrossRef
Abstract Background The prevalence of olfactory/gustatory dysfunctions among hospitalized SARS-CoV-2-infected patients is highly variable between different studies, ranging from 5.6% in the Asian population to 86% in the European population. The study aimed to detect the prevalence and the recovery of olfactory/gustatory dysfunctions in hospitalized SARS-CoV-2-infected patients in an Egyptian tertiary care center. A total of 579 hospitalized patients were enrolled. Demographic data as well as upper respiratory tract symptoms including olfactory/gustatory dysfunctions and other risk factors were documented. Then the recovery of olfactory/gustatory dysfunctions after 6 months was followed up. Results 50.6% had olfactory/gustatory dysfunctions (24.2% had a total smell and taste loss). A logistic regression analysis revealed a statistical significance between olfactory/gustatory dysfunctions and female gender and presence. Most patients (88.4%) reported partial or complete recovery during the 6 months (28.0% and 60.4%, respectively), while 11.6% of patients did not recover. The median time to start recovery was 3 days, and the median time to the best recovery was 22 days. Conclusions Olfactory/gustatory dysfunctions should be recognized for early detection of COVID-19 infection. Most recovery of olfactory/gustatory dysfunction in COVID-19 infection starts within 3 days and reaches the best recovery within 19 to 24 days. Female gender and the presence of general symptoms are associated with olfactory/gustatory dysfunctions in the hospitalized COVID-19 patients.
Title: Prevalence and outcomes of olfactory and gustatory dysfunctions in hospitalized SARS-CoV-2-infected patients
Description:
Abstract Background The prevalence of olfactory/gustatory dysfunctions among hospitalized SARS-CoV-2-infected patients is highly variable between different studies, ranging from 5.
6% in the Asian population to 86% in the European population.
The study aimed to detect the prevalence and the recovery of olfactory/gustatory dysfunctions in hospitalized SARS-CoV-2-infected patients in an Egyptian tertiary care center.
A total of 579 hospitalized patients were enrolled.
Demographic data as well as upper respiratory tract symptoms including olfactory/gustatory dysfunctions and other risk factors were documented.
Then the recovery of olfactory/gustatory dysfunctions after 6 months was followed up.
Results 50.
6% had olfactory/gustatory dysfunctions (24.
2% had a total smell and taste loss).
A logistic regression analysis revealed a statistical significance between olfactory/gustatory dysfunctions and female gender and presence.
Most patients (88.
4%) reported partial or complete recovery during the 6 months (28.
0% and 60.
4%, respectively), while 11.
6% of patients did not recover.
The median time to start recovery was 3 days, and the median time to the best recovery was 22 days.
Conclusions Olfactory/gustatory dysfunctions should be recognized for early detection of COVID-19 infection.
Most recovery of olfactory/gustatory dysfunction in COVID-19 infection starts within 3 days and reaches the best recovery within 19 to 24 days.
Female gender and the presence of general symptoms are associated with olfactory/gustatory dysfunctions in the hospitalized COVID-19 patients.

Related Results

The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Congruency of multisensory olfactory stimuli
Congruency of multisensory olfactory stimuli
Abstract We perceive our environment via different sensory channels in a multisensory fashion. During multisensory integration, these channels can enhance or hinder ...
Mutations in SARS-CoV
Mutations in SARS-CoV
The coronavirus family is named for the large spike protein molecules found on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus genome is the bi...
Coronavirus infections in monocytes and macrophages
Coronavirus infections in monocytes and macrophages
Severe cases of SARS-CoV-2, the causative agent of COVID-19, are often accompanied by dysregulated immune responses. Monocytes and Macrophages, which are part of the innate immune ...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...

Back to Top